THC Stock Overview
Operates as a diversified healthcare services company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Tenet Healthcare Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$153.35 |
| 52 Week High | US$171.20 |
| 52 Week Low | US$65.90 |
| Beta | 2.15 |
| 11 Month Change | -3.99% |
| 3 Month Change | -4.45% |
| 1 Year Change | 126.41% |
| 33 Year Change | 96.12% |
| 5 Year Change | 363.71% |
| Change since IPO | 4,543.10% |
Recent News & Updates
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Nov 17
Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services
Nov 04With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
Oct 30Recent updates
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Nov 17Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services
Nov 04With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
Oct 30Tenet Healthcare: Becoming A Very Healthy Business
Sep 09Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price
Sep 06Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)
Aug 29Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Aug 13An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued
Jul 11Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)
Jun 17With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
May 21Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit
Apr 30Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?
Mar 18Tenet Healthcare: Shrinking To Grow
Feb 04Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks
Dec 18We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt
Nov 15Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt
Oct 13Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?
Aug 02Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now
Jul 28Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?
Apr 13USPI and Providence extend hands to aid ambulatory surgical services
Feb 09Shareholder Returns
| THC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -5.9% | -4.6% | -1.2% |
| 1Y | 126.4% | 1.1% | 30.4% |
Return vs Industry: THC exceeded the US Healthcare industry which returned 1.1% over the past year.
Return vs Market: THC exceeded the US Market which returned 30.4% over the past year.
Price Volatility
| THC volatility | |
|---|---|
| THC Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: THC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: THC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 92,655 | Saum Sutaria | www.tenethealth.com |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Tenet Healthcare Corporation Fundamentals Summary
| THC fundamental statistics | |
|---|---|
| Market cap | US$14.58b |
| Earnings (TTM) | US$3.13b |
| Revenue (TTM) | US$20.97b |
4.7x
P/E Ratio0.7x
P/S RatioIs THC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THC income statement (TTM) | |
|---|---|
| Revenue | US$20.97b |
| Cost of Revenue | US$12.68b |
| Gross Profit | US$8.29b |
| Other Expenses | US$5.17b |
| Earnings | US$3.13b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 32.87 |
| Gross Margin | 39.55% |
| Net Profit Margin | 14.91% |
| Debt/Equity Ratio | 155.6% |
How did THC perform over the long term?
See historical performance and comparison